Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain.

Category Primary study
Year 2014
This is an economic evaluation that meets the criteria for inclusion on NHS EED.
Epistemonikos ID: 224038f98b304bebba3d49bfe23c666c9f5409a1
First added on: Apr 19, 2023